Robust, high-growth companies such as Adamis Pharmaceuticals are appealing to investors for many reasons. They bring about a strong upside to your portfolio, and less downside risk as opposed to financially challenged companies. Analysing the most recent financial data, I’ve created a list of companies that compare favourably in all criteria, making them potentially good additions to your portfolio.
Adamis Pharmaceuticals Corporation (NASDAQ:ADMP)
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy and respiratory disease in the United States. The company employs 117 people and has a market cap of USD $130.22M, putting it in the small-cap stocks category.
Extreme optimism for ADMP, as market analysts projected an outstanding earnings growth rate of 57.89% for the stock, supported by an equally strong sales. An affirming signal is when net income increase is supported by top-line growth. Since net income isn’t artificially inflated by one-off initiatives such as cost-cutting, we know this profit growth is more likely to be sustainable. ADMP’s bullish prospects on both the top and bottom lines make it an interesting stock to invest more time to understand how it can add value to your portfolio. A potential addition to your portfolio? Other fundamental factors you should also consider can be found here.
Pacific Premier Bancorp, Inc. (NASDAQ:PPBI)
Pacific Premier Bancorp, Inc. operates as the bank holding company for Pacific Premier Bank that provides banking services to businesses, professionals, real estate investors, and non-profit organizations. Founded in 1983, and now run by Steven Gardner, the company currently employs 844 people and has a market cap of USD $1.88B, putting it in the small-cap category.
Extreme optimism for PPBI, as market analysts projected an outstanding earnings growth rate of 54.60% for the stock, supported by an equally strong sales. An affirming signal is when net income increase is supported by top-line growth. Since net income isn’t artificially inflated by one-off initiatives such as cost-cutting, we know this profit growth is more likely to be sustainable. This prospective profitability should trickle down to shareholders, with analysts expecting the company to generate a positive return on equity of 9.94%. PPBI ticks the boxes for high-growth generation on all levels of line items, which makes it an appealing stock to dig into deeper. Could this stock be your next pick? Have a browse through its key fundamentals here.
CVB Financial Corp. (NASDAQ:CVBF)
CVB Financial Corp. operates as a bank holding company for Citizens Business Bank that provides banking, lending, trust, and investment services for small to mid-sized businesses and individuals. Started in 1974, and run by CEO Christopher Myers, the company provides employment to 685 people and has a market cap of USD $2.46B, putting it in the mid-cap group.
Want to know more about CVBF? Have a browse through its key fundamentals here.
For more financially robust companies with high growth potential to enhance your portfolio, explore this interactive list of fast growing companies.
To help readers see pass the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price sensitive company announcements.
The author is an independent contributor and at the time of publication had no position in the stocks mentioned.